Rumors that Nobel Biocare may be the target of an acquisition have pushed the company's stock to its highest point in nine years.
Nobel Biocare's stock gained 14%, the biggest jump since October 2002, after the Swiss newspaper NZZ am Sonntag reported October 23 that EQT Partners and Bain Capital are each considering buying the dental implant maker, according to a report by Bloomberg.com.
EQT -- a private equity company based in Stockholm, Sweden -- has been considering taking over Nobel Biocare "for some time," while Bain -- a Boston-based buyout fund manager -- has been waiting to see if Nobel Biocare's shares will drop further, Bloomberg said.
